Author´s Reply: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kjaer J, Smith S, Hellman P, Stalberg P, Crona J, Welin S
. Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. World J Surg. 2022; 47(2):340-347.
PMC: 9803729.
DOI: 10.1007/s00268-022-06736-1.
View
2.
Mazzaferro V, Sposito C, Coppa J, Miceli R, Bhoori S, Bongini M
. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors. Am J Transplant. 2016; 16(10):2892-2902.
DOI: 10.1111/ajt.13831.
View
3.
Shah C, Mramba L, Bishnoi R, Unnikrishnan A, Duff J, Chandana S
. Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database. J Gastrointest Oncol. 2019; 10(5):869-877.
PMC: 6776814.
DOI: 10.21037/jgo.2019.05.02.
View
4.
Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y
. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342.
PMC: 5824320.
DOI: 10.1001/jamaoncol.2017.0589.
View
5.
Norlen O, Daskalakis K, Oberg K, Akerstrom G, Stalberg P, Hellman P
. Indication for liver transplantation in young patients with small intestinal NETs is rare?. World J Surg. 2013; 38(3):742-7.
DOI: 10.1007/s00268-013-2331-z.
View